Camp4 Therapeutics (CAMP) Change in Cash (2023 - 2026)

Camp4 Therapeutics has disclosed Change in Cash across 4 years of filings, most recently posting -$10.9 million for Q1 2026.

• Change in Cash for Q1 2026 came in at -$10.9 million, up 25.77% year-over-year; the trailing twelve-month figure through Mar 2026 was $49.9 million (up 123.67% YoY), and the FY2025 annual result was $46.1 million, up 79.64% from the prior year.
• Change in Cash came in at -$10.9 million for Q1 2026 at Camp4 Therapeutics, down from $34.9 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $61.5 million in Q4 2024 to a low of -$14.7 million in Q1 2025.
• The 4-year median for Change in Cash is -$10.6 million (2025), against an average of $4.9 million.
• Across the five-year window, Change in Cash jumped 608.82% in 2024 and plunged 43.3% in 2025, its largest moves.
• Camp4 Therapeutics' Change in Cash stood at -$12.1 million in 2023, then surged by 608.82% to $61.5 million in 2024, then slumped by 43.3% to $34.9 million in 2025, then plunged by 131.32% to -$10.9 million in 2026.
• The last three Change in Cash figures came in at -$10.9 million (Q1 2026), $34.9 million (Q4 2025), and $36.2 million (Q3 2025), per Business Quant data.